Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Chemical Engineers are Beginning to Play a Leading Role in the Treatment of Cancers

Published: Monday, July 08, 2013
Last Updated: Monday, July 08, 2013
Bookmark and Share
Engineers are helping to combat drug resistance and finding better ways of delivering treatments directly at tumours.

Cancer treatments often include a mix of therapies including chemotherapy, growth inhibitors and radiation therapy.

Success is dependent on many factors, but multi-drug resistance by the cancerous cells and the inability to deliver chemotherapy treatments directly to tumours in high enough concentrations are just some of the obstacles to a successful outcome.

It’s a problem which is attracting the attention of chemical engineers who are looking at new ways to treat cancer. One example is using ‘nanomaterials’ to carry drugs into affected areas in combination with experimental photothermal therapies.

Nanomaterials, such as Nanographene oxide (NGO), are able to penetrate the relatively large gaps (100-600nm) found in tumours to target cancerous cells more effectively.  By changing the size and surface properties of the nanomaterials, chemical engineers are also able to control how the drugs are distributed around the body to help avoid damaging non-cancerous cells.

Drugs carried by nanomaterials have other distinct advantages over ‘small molecule drugs’, which are quickly metabolised and removed from the human body by the kidneys. Standard drugs also have greater side effects caused by the high dosages needed to treat the cancers.

A recent study1 by chemical engineers in Taiwan, using nanomaterials technology combined with other cancer treatments, were able to increase the local drug concentration six fold and suppress tumour development more efficiently. Their results also suggested treatment was less toxic, with reduced side effects, and no multi-drug resistance.

David Brown, chief executive of the Institution of Chemical Engineers (IChemE), said: “Recent analysis by the charity Macmillan Cancer Support projects that in 2020 nearly one in two people (47%) in the UK will get cancer in his or her lifetime.

“These are dramatic statistics and put increasing pressure on the health sector and professionals like chemical engineers to find better treatments and cures for cancer.

“It’s great to see chemical engineers making their own significant contribution in this field in this latest piece of research from Taiwan and other projects we know are underway in many other countries around the world.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Artificial Nose Matches Human Sense of Smell
Chemical engineers in South Korea have successfully created nanobioelectronic nose.
Monday, June 24, 2013
Scientific News
New CAR T Cell Therapy Using Double Target Aimed at Solid Tumors
Researchers at Penn University have described how antibody, carbohydrate combination could apply to range of cancer types.
Erasing Unpleasant Memories with a Genetic Switch
Researchers from KU Leuven and the Leibniz Institute for Neurobiology have managed to erase unpleasant memories in mice using a 'genetic switch'.
New Method Detects Telomere Length for Research into Cancer, Aging
UT Southwestern Medical Center cell biologists have identified a new method for determining the length of telomeres, the endcaps of chromosomes, which can influence cancer progression and aging.
Assessing the Effectiveness of Genome-Editing Technologies
Researchers have developed a cost-effective and rapid method for assessing edits generated by CRISPR-Cas9 and other genome-editing technologies.
New Cancer Drug Target Found in Dual-Function Protein
Findings from a study from TSRI have shown that targeting a protein called GlyRS might help to halt cancer growth.
Alzheimer's Genetics Point To New Research Direction
A University of Adelaide analysis of genetic mutations which cause early-onset Alzheimer’s disease suggests a new focus for research into the causes of the disease.
Contagious Cancers Are Spreading in Shellfish
Direct transmission of cancer among some marine animals may be more common than once thought, suggests a new study published in Nature by researchers at Columbia University Medical Center (CUMC).
Contagious Cancers Are Spreading in Shellfish
Direct transmission of cancer among some marine animals may be more common than once thought, suggests a new study published in Nature by researchers at Columbia University Medical Center (CUMC).
Fix for 3-Billion-Year-Old Genetic Error
Researchers at The University of Texas at Austin have developed a fix that allows RNA to accurately proofread for the first time.
Higher Frequency of Huntington's Disease Mutations Discovered
University of Aberdeen study shows that the gene change that causes Huntington's disease is much more common than previously thought.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!